These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11709708)

  • 21. DNA binding domain-independent pathways are involved in EWS/FLI1-mediated oncogenesis.
    Welford SM; Hebert SP; Deneen B; Arvand A; Denny CT
    J Biol Chem; 2001 Nov; 276(45):41977-84. PubMed ID: 11553628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest.
    Rowland BD; Denissov SG; Douma S; Stunnenberg HG; Bernards R; Peeper DS
    Cancer Cell; 2002 Jul; 2(1):55-65. PubMed ID: 12150825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis.
    Bachoo RM; Maher EA; Ligon KL; Sharpless NE; Chan SS; You MJ; Tang Y; DeFrances J; Stover E; Weissleder R; Rowitch DH; Louis DN; DePinho RA
    Cancer Cell; 2002 Apr; 1(3):269-77. PubMed ID: 12086863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restoration of p16INK4A protein induces myogenic differentiation in RD rhabdomyosarcoma cells.
    Urashima M; Teoh G; Akiyama M; Yuza Y; Anderson KC; Maekawa K
    Br J Cancer; 1999 Mar; 79(7-8):1032-6. PubMed ID: 10098732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis.
    Inoue K; Wen R; Rehg JE; Adachi M; Cleveland JL; Roussel MF; Sherr CJ
    Genes Dev; 2000 Jul; 14(14):1797-809. PubMed ID: 10898794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. JunD protects cells from p53-dependent senescence and apoptosis.
    Weitzman JB; Fiette L; Matsuo K; Yaniv M
    Mol Cell; 2000 Nov; 6(5):1109-19. PubMed ID: 11106750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The oncogenic properties of EWS/WT1 of desmoplastic small round cell tumors are unmasked by loss of p53 in murine embryonic fibroblasts.
    Bandopadhayay P; Jabbour AM; Riffkin C; Salmanidis M; Gordon L; Popovski D; Rigby L; Ashley DM; Watkins DN; Thomas DM; Algar E; Ekert PG
    BMC Cancer; 2013 Dec; 13():585. PubMed ID: 24321497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression.
    Maeda T; Hobbs RM; Merghoub T; Guernah I; Zelent A; Cordon-Cardo C; Teruya-Feldstein J; Pandolfi PP
    Nature; 2005 Jan; 433(7023):278-85. PubMed ID: 15662416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tetracycline-regulatable factors with distinct dimerization domains allow reversible growth inhibition by p16.
    Rossi FM; Guicherit OM; Spicher A; Kringstein AM; Fatyol K; Blakely BT; Blau HM
    Nat Genet; 1998 Dec; 20(4):389-93. PubMed ID: 9843215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arf tumor suppressor promoter monitors latent oncogenic signals in vivo.
    Zindy F; Williams RT; Baudino TA; Rehg JE; Skapek SX; Cleveland JL; Roussel MF; Sherr CJ
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15930-5. PubMed ID: 14665695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor suppressor p16INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes.
    Drayton S; Rowe J; Jones R; Vatcheva R; Cuthbert-Heavens D; Marshall J; Fried M; Peters G
    Cancer Cell; 2003 Oct; 4(4):301-10. PubMed ID: 14585357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Arf-Egr-C/EBPβ pathway linked to ras-induced senescence and cancer.
    Salotti J; Sakchaisri K; Tourtellotte WG; Johnson PF
    Mol Cell Biol; 2015 Mar; 35(5):866-83. PubMed ID: 25535333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization and drug resistance patterns of Ewing's sarcoma family tumor cell lines.
    May WA; Grigoryan RS; Keshelava N; Cabral DJ; Christensen LL; Jenabi J; Ji L; Triche TJ; Lawlor ER; Reynolds CP
    PLoS One; 2013; 8(12):e80060. PubMed ID: 24312454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferation: the cell cycle.
    Serrano M
    Adv Exp Med Biol; 2003; 532():13-7. PubMed ID: 12908545
    [No Abstract]   [Full Text] [Related]  

  • 35. Proteomic comparison of the EWS-FLI1 expressing cells EF with NIH-3T3 and actin remodeling effect of (R/W)
    Clavier S; Illien F; Sagan S; Bolbach G; Sachon E
    EuPA Open Proteom; 2016 Mar; 10():1-8. PubMed ID: 29900093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of p19Arf promotes fibroblast survival during leucine deprivation.
    Roby KC; Lieberman A; Kim BJ; Rodríguez NZ; Posimo JM; Tsang T; Verginadis II; Puré E; Brady DC; Koumenis C; Ryeom S
    Biol Open; 2022 Feb; 11(2):. PubMed ID: 34994382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue microarrays: applications in study of p16 and p53 alterations in Ewing's cell lines.
    Noguera R; Machado I; Piqueras M; Lopez-Guerrero JA; Navarro S; Mayordomo E; Pellin A; Llombart-Bosch A
    Diagn Pathol; 2008 Jul; 3 Suppl 1(Suppl 1):S27. PubMed ID: 18673516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The oncogenic role of the cochaperone Sgt1.
    Ogi H; Sakuraba Y; Kitagawa R; Xiao L; Shen C; Cynthia MA; Ohta S; Arnold MA; Ramirez N; Houghton PJ; Kitagawa K
    Oncogenesis; 2015 May; 4(5):e149. PubMed ID: 25985210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.
    Hahm KB
    Nat Genet; 1999 Dec; 23(4):481. PubMed ID: 10581042
    [No Abstract]   [Full Text] [Related]  

  • 40. Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.
    Javaheri T; Kazemi Z; Jan Pencik ; Pham HTT; Kauer M; Noorizadeh R; Sax B; Nivarthi H; Schlederer M; Maurer B; Hofbauer M; Aryee DNT; Wiedner M; Tomazou EM; Logan M; Hartmann C; Tuckermann JP; Kenner L; Mikula M; Dolznig H; Üren A; Richter GH; Grebien F; Kovar H; Moriggl R
    Cell Death Dis; 2018 Jul; 9(8):800. PubMed ID: 30038364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.